Europe - Euronext Amsterdam - AMS:GLPG - BE0003818359 - Common Stock
Taking everything into account, GLPG scores 2 out of 10 in our fundamental rating. GLPG was compared to 85 industry peers in the Biotechnology industry. While GLPG seems to be doing ok healthwise, there are quite some concerns on its profitability. GLPG does not seem to be growing, but still is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.42% | ||
| ROE | -17.83% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 84.31% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.58 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 8.63 | ||
| Quick Ratio | 8.56 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ChartMill assigns a fundamental rating of 2 / 10 to GLPG.AS.
ChartMill assigns a valuation rating of 0 / 10 to GALAPAGOS NV (GLPG.AS). This can be considered as Overvalued.
GALAPAGOS NV (GLPG.AS) has a profitability rating of 2 / 10.